Volitionrx

VNRXNYSE Singapore Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$7.392 M

$0.26 +1.88%

Close of 21 Sept 2026

Revenue

$1.73M

#3435 by revenue

Earnings

-$23.4M

Loss-making

Shares outstanding

13,649,384

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#13ImmucellICCC$92.0M
#14BiomericaBMRA$11.9M
#15VolitionrxVNRX$7.39M
#16Q/C TechnologiesQCLS$6.43M
#17Trinity BiotechTRIB$5.98M

What if Volitionrx were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,084,962

Per share 4,095,743× higher

Bitcoin $1.72T

$61,634.36

Per share 232,670× higher

Nvidia $5.48T

$196,387.27

Per share 741,364× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Volitionrx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.